These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5663629)

  • 21. Pharmacological studies of a new series of bicyclic thymoleptics.
    Petersen PV; Lassen N; Hansen V; Huld T; Hjortkjaer J; Holmblad J; Nielsen IM; Nymark M; Pedersen V; Jorgensen A; Hougs W
    Acta Pharmacol Toxicol (Copenh); 1966; 24(2):121-33. PubMed ID: 4165059
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of 1-p-acetyldeoxyephedrine and 4-methyl- -ethyl-m-tyramine as to lowering of brain serotonin, and their antagonism by antidepressants.
    Dubnick B; Rucki EW; Salama AI
    Eur J Pharmacol; 1973 May; 22(2):121-8. PubMed ID: 4715214
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective inhibitors of monoamine oxidase. 2. Arylamide SAR.
    Harfenist M; Joyner CT; Mize PD; White HL
    J Med Chem; 1994 Jun; 37(13):2085-9. PubMed ID: 8027990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New indolyl peptidyl esters as MAO inhibitors.
    Sharma M; Gujrati VR; Nath C; Bhargava KP; Shanker K
    Pharmacol Res Commun; 1982 Oct; 14(9):827-37. PubMed ID: 7178212
    [No Abstract]   [Full Text] [Related]  

  • 25. Antidepressive effect of N-3,4,5-trimethoxybenzoyl heptamethylenimine.
    Pálosi E; Szporny L; Nádor K
    J Pharm Sci; 1968 Apr; 57(4):709-10. PubMed ID: 5652172
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective inhibitors of monoamine oxidase (MAO). 5. 1-Substituted phenoxathiin inhibitors containing no nitrogen that inhibit MAO A by binding it to a hydrophobic site.
    Harfenist M; McGee DP; Reeves MD; White HL
    J Med Chem; 1998 Jun; 41(12):2118-25. PubMed ID: 9622553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
    Fuxe K; Hökfelt T
    Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
    [No Abstract]   [Full Text] [Related]  

  • 28. New indolyl MAO inhibitors. Part 2.
    Sathi G; Gujrati VR; Nath C; Bhargava KP; Shanker K
    Pharmazie; 1982 Dec; 37(12):868-9. PubMed ID: 7163376
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacological evaluation of 3-(N-3,3-diphenylpropyl-N-methyl)-aminopropan-1-ol-hydrochloride (PF-82), a new type of antidepressant drug.
    Shimizu M; Hirooka T; Karasawa T; Masuda Y; Oka M
    Arzneimittelforschung; 1974 Feb; 24(2):166-73. PubMed ID: 4207353
    [No Abstract]   [Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of oxindole derivatives as antidepressive agents.
    Suthar SK; Bansal S; Alam MM; Jaiswal V; Tiwari A; Chaudhary A; Alex AT; Joseph A
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5281-5. PubMed ID: 26428872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newer formazans and tetrazolium indoles as potential CNS-active agents.
    Sathi G; Gujrati VR; Nath C; Agarwal JC; Bhargava KP; Shanker K
    Arzneimittelforschung; 1983; 33(9):1218-21. PubMed ID: 6685502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of a number of drugs with different pharmacological properties upon reserpine induced hypothermia in mice.
    van Riezen H; Delver A
    Arzneimittelforschung; 1971 Oct; 21(10):1562-6. PubMed ID: 4400402
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of monoamine oxidase by N-(phenoxyethyl)cyclopropylamines. Correlation of inhibition with Hammett constants and partition coefficients.
    Fuller RW; Marsh MM; Mills J
    J Med Chem; 1968 Mar; 11(2):397-8. PubMed ID: 5663643
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemistry and pharmacology of a new potential antidepressant. (N-methyl-N-[4-chlorobenzyl-methyl-3-(10,11-dihydro-5H-dibenz(b,f) azepin-5-yl)]-propylamine hydrochloride). (Leo 640, lopraminehydrochloride).
    Eriksoo E; Rohte O
    Arzneimittelforschung; 1970 Oct; 20(10):1561-9. PubMed ID: 4394726
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and screening of cyclic benzylhydrazine congeners as antidepressants.
    Taha AM; Omar NM; Bayomi SM; Ammar EM; Afifi A
    J Pharm Sci; 1974 Mar; 63(3):395-8. PubMed ID: 4820369
    [No Abstract]   [Full Text] [Related]  

  • 36. (+/-)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 1. Synthesis and evaluation of (+/-)-4,5-dihydro-2,3-dimethyl-4-phenyl-3H-1,3-benzodiazepine and analogues as potential antidepressant agents.
    Geyer HM; Martin LL; Crichlow CA; Dekow FW; Ellis DB; Kruse H; Setescak LL; Worm M
    J Med Chem; 1982 Apr; 25(4):340-6. PubMed ID: 7200144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On the psychopharmalogic characteristics and a clinical evaluation of the therapeutic effect of antidepressants].
    Stoianov S; Antonov L
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(3):419-28. PubMed ID: 5795729
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man.
    Martini A; Bonollo L; Nicolis FB; Sega R; Palermo A; Braibanti E
    Br J Clin Pharmacol; 1981 Jun; 11(6):605-10. PubMed ID: 7272177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adrenergic mechanisms of antidepressant action].
    Mashkovskiĭ MD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):750-9. PubMed ID: 4916171
    [No Abstract]   [Full Text] [Related]  

  • 40. Anticonvulsant activity and monoamine oxidase inhibitory properties of 1,3,5-trisubstituted pyrazolines.
    Parmar SS; Pandey BR; Dwivedi C; Harbison RD
    J Pharm Sci; 1974 Jul; 63(7):1152-5. PubMed ID: 4850598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.